Signal Enhancement in Immunoassays via Coupling to Catalytic Nanoparticles
Open Access
- 20 May 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (6) , 4622-4633
Abstract
Early diagnosis is vital for effective disease management, selection of appropriate treatment regimes, and surveillance and control of disease transmission. There is a growing need for point-of-need diagnostic platforms, such as lateral flow immunoassays (LFIAs), to reduce healthcare burdens, particularly in low-resource settings. However, LFIAs often suffer from inadequate sensitivity and exhibit limited dynamic ranges, leading to late-stage diagnosis or misdiagnosis. Here, we present a signal enhancement platform for use in both plate- and paper-based immunoassays, based on the formation of a coupled nanoparticle network. We demonstrate the coupling of an antigen-targeting detection probe with a secondary, catalytically active nanoparticle by utilizing secondary antibody interactions. Here, we show that signal enhancement is achieved through two functional mechanisms: network formation, facilitated by the secondary nanoparticle increasing the relative concentration of nanoparticles immobilized at the test zone; and the inclusion of catalytically active nanoparticles, which catalyze the oxidation of a chromogenic substrate at the test zone. Through this approach, we yielded a 40-fold improvement in the limit of detection (LOD) using 40 nm gold nanoparticle detection probes in spiked pooled human saliva. Further, the signal enhancement platform can be utilized alongside a range of detection probes, including gold nanoparticles, commonly employed for use in LFIAs. This work concludes by showcasing that the signal enhancement mechanism is compatible for use with complex sample matrices, such as human saliva.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/K031953/1, EP/R00529X/1)
- Royal Academy of Engineering (CiET2021\94)
- Wellcome Trust (222836/Z/21/Z)
- University of Oxford
- Rosetrees Trust
- Department for Science, Innovation and Technology
- Cancer Research UK (100063, CANCTA-2023\100006)
This publication has 35 references indexed in Scilit:
- Diagnostics of Alzheimer’s disease using fluorescent nanodiamond-based spin-enhanced lateral flow immunoassayMicrochemical Journal, 2024
- Sub-picomolar lateral flow antigen detection with two-wavelength imaging of composite nanoparticlesBiosensors and Bioelectronics, 2022
- Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivityMicrochimica Acta, 2021
- A decentralised point-of-care testing model to address inequities in the COVID-19 responseThe Lancet Infectious Diseases, 2021
- ASSURED‐compliant point‐of‐care diagnostics for the detection of human viral infectionsReviews in Medical Virology, 2021
- Dual-color magnetic-quantum dot nanobeads as versatile fluorescent probes in test strip for simultaneous point-of-care detection of free and complexed prostate-specific antigenBiosensors and Bioelectronics, 2019
- Statistical Method for Determining and Comparing Limits of Detection of BioassaysAnalytical Chemistry, 2015
- A three-line lateral flow assay strip for the measurement of C-reactive protein covering a broad physiological concentration range in human seraBiosensors and Bioelectronics, 2014
- Signal enhancement in a lateral flow immunoassay based on dual gold nanoparticle conjugatesClinical Biochemistry, 2013
- A dual gold nanoparticle conjugate-based lateral flow assay (LFA) method for the analysis of troponin IBiosensors and Bioelectronics, 2010